1 min read

Considerations for Migrating a Drug Product Presentation from Vial to Pre-Filled Syringe

1 min read

An increasing number of pharmaceutical companies are searching for Contract Development and Manufacturing Organizations (CDMOs) that can support them in converting an existing product presentation into a different final container type.

Most often, the tech transfer required is in converting drug products from a vial into a prefilled syringe (PFS). From the patient centricity benefits to product safety enhancements, the demand for PFS treatments has skyrocketed, and CDMOs must keep up.

This whitepaper outlines the benefits of PFS transfer, the differences between glass and PFS devices, and the key engineering processes required to successfully carry out this process.

You can download the full white paper by completing the form below.

Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please tick the box below.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.